Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Axial Spondyloarthritis Patients, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 4-Year Outcomes from the Rapid-Axs ...
Abstract
Authors
J Sieper A Kivitz A van Tubergen A Deodhar K Harris T Nurminen R Landewé